BeOne Medicines
ONC
#688
Rank
A$51.56 B
Marketcap
A$466.02
Share price
0.75%
Change (1 day)
65.03%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): A$0.85

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is A$0.98. In 2024 the company made an earnings per share (EPS) of A-$9.43.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.85-109.06%
2024A-$9.43
2022A-$29.4728.21%
2021A-$22.99-19.96%
2020A-$28.7220.81%
2019A-$23.7731.52%
2018A-$18.08417.57%
2017A-$3.49-37.16%
2016A-$5.56158.95%
2015A-$2.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.44-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
A-$0.36-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA